Hanson, Maureen R, Gu, Zhenglong, Keinan, Alon et al. · Journal of translational medicine · 2016 · DOI
This study looked at whether variations in mitochondrial DNA (the genetic material in the energy-producing parts of our cells) are linked to ME/CFS. Researchers compared genetic samples from ME/CFS patients and healthy people. While they didn't find that specific DNA variants caused the disease itself, they did discover that certain genetic variations were associated with specific symptoms and how severe those symptoms were.
Understanding how mitochondrial genetic variations relate to ME/CFS symptoms could help explain why patients experience different symptom patterns and severities. This research opens a new avenue for investigating the biological basis of ME/CFS beyond simply looking at whether someone has the disease, potentially leading to better symptom management and personalized treatment approaches.
This study does not prove that mitochondrial DNA variants cause ME/CFS. It also does not establish that these genetic variations directly determine symptom severity—only that they are statistically associated. The findings are correlational and require validation in larger, independent populations before clinical implications can be determined.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →